Literature DB >> 8276722

Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.

Y Nakabo1, N Harakawa, K Yamamoto, M Okuma, K Uno, M Sasada.   

Abstract

In this study, we analyzed the mechanism(s) of leukemic cell lysis by human macrophages. Peripheral blood monocyte-derived macrophages were activated with recombinant interferon-gamma and lipopolysaccharide and their lytic activity against two leukemic cell lines (K562 and HL-60 cells) was assessed by an 111In releasing assay. Activated macrophages lysed these leukemic cells, and the lytic activity against leukemic cells was almost completely inhibited by anti-tumor necrosis factor (TNF) antibody. The macrophage-lysate prepared from activated macrophages also exhibited significant lytic activity against leukemic cells; this lytic activity was inhibited by anti-TNF antibody. The leukemic cells that we used for the cytotoxicity assays were resistant to recombinant TNF. The culture supernatant of activated macrophages did not show any lytic activity. These findings suggest that cell-associated TNF plays a role in macrophage-mediated cytotoxicity against leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276722      PMCID: PMC5919082          DOI: 10.1111/j.1349-7006.1993.tb02818.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  48 in total

1.  Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

Authors:  K H Grabstein; D L Urdal; R J Tushinski; D Y Mochizuki; V L Price; M A Cantrell; S Gillis; P J Conlon
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

2.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

3.  Involvement of leukocyte (beta 2) integrins (CD18/CD11) in human monocyte tumoricidal activity.

Authors:  S Bernasconi; G Peri; M Sironi; A Mantovani
Journal:  Int J Cancer       Date:  1991-09-09       Impact factor: 7.396

4.  Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.

Authors:  R H Wiltrout; D Taramelli; H T Holden
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

5.  Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

6.  Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.

Authors:  A Sampson-Johannes; J A Carlino
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

7.  Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes.

Authors:  M Malkovský; B Loveland; M North; G L Asherson; L Gao; P Ward; W Fiers
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

8.  Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.

Authors:  A R Chen; K P McKinnon; H S Koren
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

10.  Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

Authors:  J L Urban; H M Shepard; J L Rothstein; B J Sugarman; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

View more
  2 in total

1.  Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.

Authors:  W Lasek; A Wańkowicz; K Kuc; W Feleszko; J Gołab; A Giermasz; W Wiktor-Jedrzejczak; M Jakóbisiak
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

2.  Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C.

Authors:  Y Nakabo; M J Pabst
Journal:  Jpn J Cancer Res       Date:  1998-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.